Navigation Links
Cell Biosciences Announces First UK System Sale
Date:3/10/2009

PALO ALTO, Calif., March 10 /PRNewswire/ -- Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the sale of its flagship protein analysis system to The University of Manchester's Stem Cell and Leukaemia Proteomics Laboratory, led by Professor Tony Whetton. Professor Whetton is a pioneer in the use of advanced proteomics technologies to understand biological processes in normal and leukaemic stem cells. The Cell Biosciences system will be used to study how phosphoprotein signaling processes in hematopoietic stem cells are affected during leukaemia.

"My laboratory has developed a number of new methods to look at changes in protein status within cells," said Professor Whetton. "We believe that the Cell Biosciences system will provide important new insights into the effect of leukaemogenic proteins on stem cell processes."

The Cell Biosciences platform is an ultrasensitive nanofluidic immunoassay system designed to analyze extremely small biological samples. Traditional protein analysis techniques can require as many as 100,000 cells, which complicates protein analysis in stem cells and other precious samples. Because of the Cell Biosciences system's high detection sensitivity, it can measure cell signaling proteins reproducibly in as few as 25 cells.

"The University of Manchester is an ideal location for our first UK placement," said Tim Harkness, President and Chief Executive Officer at Cell Biosciences. "We are pleased to see our products adopted by such a prestigious institution."

Cancer research in Manchester recently was rated best in the UK by the government-led Research Assessment Exercise (RAE), a comprehensive assessment of the quality of research at UK universities. The University of Manchester represents the second Cell Biosciences system sale in Europe.

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on nanoproteomics. We develop instrumentation systems and assays for the measurement of phosphoprotein signaling and activation in extremely small biological samples. Our company's lead product is a capillary-based nanofluidic immunoassay platform that provides quantitative and reproducible data on key signaling pathways in precious biological samples, such as small tumor biopsies and stem cells. Cell Biosciences is located in Palo Alto, California.

www.cellbiosciences.com

info@cellbiosciences.com


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Regado Biosciences to Present at the 2009 Wharton Healthcare Business Conference
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results
3. Enlight Biosciences Expands to direct up to $52 Million to Transformational Enabling Technologies
4. New Jersey-Based Biotech Start-Up Nexomics Biosciences Gets Off the Ground
5. URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology
6. URMC, Lighthouse Biosciences awarded US patent for diagnostic technology
7. Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis
8. CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
9. Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus
10. Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
11. Cell Biosciences Introduces First Protein Analysis Kits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: